Home › Entities › doctoral_thesis › Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration

Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration

2011 doctoral thesis by Thilini Thrimawithana at University of Auckland
Place doctoral_thesis Q112200925
Press Enter · cited answer in seconds

Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration

Summary

Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration is a doctoral thesis[1].

Key Facts

  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration authored A Novel Treatment Strategy for Age-Related Macular Degeneration — author (P50): Thilini Thrimawithana[2].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's instance of is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — instance of (P31): doctoral thesis[3].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's publisher is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — publisher (P123): ResearchSpace@Auckland[4].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's copyright license is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — copyright license (P275): Creative Commons Attribution-NonCommercial-NoDerivs 3.0 New Zealand[5].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's country of origin is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — country of origin (P495): New Zealand[6].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's publication date is recorded as +2011-00-00T00:00:00Z[7].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/6983[8].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's Handle ID is recorded as 2292/6983[9].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's title is recorded as Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration[10].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's copyright holder is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — copyright holder (P3931): Thilini Thrimawithana[11].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's thesis submitted to is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — thesis submitted to (P4101): University of Auckland[12].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's on focus list of Wikimedia project is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — on focus list of Wikimedia project (P5008): NZThesisProject[13].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's copyright status is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — copyright status (P6216): copyrighted[14].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's online access status is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — online access status (P6954): open access[15].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's thesis committee member is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — thesis committee member (P9161): Raid Ghassan Alany[16].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's thesis committee member is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — thesis committee member (P9161): Colin Green[17].
  • Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's thesis committee member is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — thesis committee member (P9161): Simon Anthony Young[18].

Body

Designation and Status

Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration's instance of is recorded as A Novel Treatment Strategy for Age-Related Macular Degeneration — instance of (P31): doctoral thesis[3].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [3] ↑ . wikidata.org.
  2. [2] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration. Retrieved May 3, 2026, from https://4ort.xyz/entity/polymeric-systems-for-transscleral-delivery-of-antisense-oligonucleotides-a-novel-treatment-strategy-for-age-related-macular-degeneration
MLA “Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/polymeric-systems-for-transscleral-delivery-of-antisense-oligonucleotides-a-novel-treatment-strategy-for-age-related-macular-degeneration.
BibTeX @misc{4ortxyz_polymeric-systems-for-transscleral-delivery-of-antisense-oligonucleotides-a-novel-treatment-strategy-for-age-related-macular-degeneration_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration}}, year = {2026}, url = {https://4ort.xyz/entity/polymeric-systems-for-transscleral-delivery-of-antisense-oligonucleotides-a-novel-treatment-strategy-for-age-related-macular-degeneration}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Polymeric Systems for Transscleral Delivery of Antisense Oligonucleotides: A Novel Treatment Strategy for Age-Related Macular Degeneration — https://4ort.xyz/entity/polymeric-systems-for-transscleral-delivery-of-antisense-oligonucleotides-a-novel-treatment-strategy-for-age-related-macular-degeneration (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/polymeric-systems-for-transscleral-delivery-of-antisense-oligonucleotides-a-novel-treatment-strategy-for-age-related-macular-degeneration · Last refreshed: